Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 190.99-84.21-1.87172.3626.79

What is the latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM is 190.99 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025190.99
Mar2024-84.21
Mar2023-1.87
Mar2022172.36
Mar202126.79

How is Core EBITDA Growth of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 190.99
Positive
Mar2024 -84.21
Negative
Mar2023 -1.87
Negative
Mar2022 172.36
543.37
Mar2021 26.79 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹76.4 Cr -2.3% -10.5% -38.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,581.0 Cr -1.8% 4.1% -1.6% Stock Analytics
DIVIS LABORATORIES ₹167,051.0 Cr -2.8% -3.7% 2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,367.0 Cr -0.2% -0.9% 12.9% Stock Analytics
CIPLA ₹120,289.0 Cr -2.1% -1.7% 0.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,421.0 Cr -2% 3.3% -0.6% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-2.3%

-10.5%

-38.4%

SENSEX

-0.8%

1%

3.2%


You may also like the below Video Courses